Invenomic Fund Investor Class shares
BIVRX
NASDAQ
| Weiss Ratings | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C- | |||
| Risk Index | Fair | |||
| Risk Grade | C+ | |||
| Company Info | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Invenomic | |||
| Manager/Tenure (Years) | Benjamin R. Deschaine (9), Ali Motamed (9) | |||
| Website | http://www. invenomic.com | |||
| Fund Information | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Invenomic Fund Investor Class shares | |||
| Category | Long-Short Equity | |||
| Sub-Category | Long/Short Equity | |||
| Prospectus Objective | Growth | |||
| Inception Date | Jun 19, 2017 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 5,000.00 | |||
| Minimum Subsequent Investment | 500.00 | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.79% | |||
| Dividend | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.46% | |||
| Asset Allocation | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 81.30% | |||
| Stock | 18.70% | |||
| U.S. Stock | 16.58% | |||
| Non-U.S. Stock | 2.12% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 2.73% | |||
| 30-Day Total Return | 3.67% | |||
| 60-Day Total Return | 18.54% | |||
| 90-Day Total Return | 29.50% | |||
| Year to Date Total Return | 10.54% | |||
| 1-Year Total Return | 8.63% | |||
| 2-Year Total Return | 14.96% | |||
| 3-Year Total Return | 9.17% | |||
| 5-Year Total Return | 115.52% | |||
| Price | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $19.18 | |||
| 1-Month Low NAV | $17.10 | |||
| 1-Month High NAV | $19.18 | |||
| 52-Week Low NAV | $13.51 | |||
| 52-Week Low NAV (Date) | Jun 22, 2026 | |||
| 52-Week High NAV | $19.83 | |||
| 52-Week High Price (Date) | Jul 29, 2026 | |||
| Beta / Standard Deviation | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.55 | |||
| Standard Deviation | 22.82 | |||
| Balance Sheet | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 877.02M | |||
| Operating Ratios | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 3.30% | |||
| Turnover Ratio | 197.00% | |||
| Performance | BIVRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 9.98% | |||
| Last Bear Market Total Return | 5.89% | |||